I am here for all interesting and funny posts on the social sciences, broadly understood and including open science and meta science, academia, teaching and research. https://linktr.ee/ingorohlfing
Reposted by Ingo Rohlfing
open.substack.com/pub/thebsdet...
review-of-financial-studies.github.io/readme.html An extensive checklist that is very useful. README files are likely something that is left for LLMs in the future, but it could be based on this template then. #OpenScience
Reposted by Ingo Rohlfing
Reposted by Ingo Rohlfing
1) in polisci, which is more open to qual methods/soft data than econ, the claude code shock may mean that qual data & original measurements will increase value
2) that "hopefully" is doing *a lot* of work but again women tend to select in qual meth so 🤞
Reposted by Brian A. Nosek, Dan Goldhaber, Brendan Nyhan , and 32 more Brian A. Nosek, Dan Goldhaber, Brendan Nyhan, James P. Collins, Ben Bond‐Lamberty, Ruth Dassonneville, Alistair Munro, Jörg Peters, Brian Schaffner, Caroline Krafft, Philip N. Cohen, Alexander Wuttke, John Holbein, Justin H. Kirkland, Chris Hanretty, Scott Clifford, Valerie Mueller, Ingo Rohlfing, Michael Kevane, Flávio Azevedo, Max Nathan, Veli‐Matti Karhulahti, Philip Cowley, Julia Lynch, Juan Moreno‐Cruz, Madeleine Pownall, Patrick Präg, Marcus Credé, Stuart J. Turnbull‐Dugarte, Tom Louwerse, Aleksandra Urman, Samuel Coavoux, Jake Anders, Roman Senninger, Joan Dudney
Reposted by Ingo Rohlfing, Damien Bol
This is probably overstated, but if you're an early-career academic, it's worth taking seriously that tenured Stanford professors who've been working with AI more than most are saying things like this out loud now.
Reposted by Joshua Goodman, Ingo Rohlfing, Juan Moreno‐Cruz
This is probably overstated, but if you're an early-career academic, it's worth taking seriously that tenured Stanford professors who've been working with AI more than most are saying things like this out loud now.
Reposted by Ingo Rohlfing
There are probably many benefits of sharing clinical trial data, including:
Verifying results, better meta-analysis, understanding inconsistent results, further exploration, better clinical decision-making, learning how to run trials better, and reducing redundancy.
Reposted by Ingo Rohlfing
With @jessicahullman.bsky.social and @statmodeling.bsky.social
juliarohrer.com/wp-content/u...
Reposted by Alexander Wuttke, Leibniz-Informationszentrum Wirtschaft
expedition-open-science.org This is a lightweight, but very useful and accessible intro to key elements of Open Science (online and as a PDF). Seems particularly useful for introducing the topic to undergraduates @zbw-leibniz.bsky.social
Reposted by Ingo Rohlfing, Margot C. Finn, Benjamin Klement
metaresearch.nl/blog/2026/2/...
Reposted by Ingo Rohlfing, Ian Hussey, José Pina-Sánchez
Reposted by Michael Barnett, Brian A. Nosek, Steven Van de Walle , and 11 more Michael Barnett, Brian A. Nosek, Steven Van de Walle, Ben Barr, Anne Rasmussen, Alexander Wuttke, John Holbein, Justin H. Kirkland, Valerie Mueller, Ingo Rohlfing, Michael Kevane, Dean Eckles, David Szakonyi, Roman Senninger
We show that even well-identified DiD studies are often underpowered; sample sizes needed are surprisingly large
Paper: osf.io/preprints/os... 1/6
www.insidehighered.com/news/faculty...
In what way do we get to our senses? That more studies estimate power, or acknowledge that power is likely to be low?
Maybe the editors have a different view because, according to the online-first articles, most seem to work with survey, firm or country data 2/
I am fine with anyone having a different read of and view on this. Personally, I find prereg with ex ante accessibility of 1/